Celgene won't initiate phase 3 trial for Crohn's disease drug
October 19, 2017 at 16:35 PM EDT
Celgene said Thursday that it won't initiate a phase 3 trial for a Crohn's disease drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.